TABLE 1.
Drug | No gene (0.01, 0.1, 1) | MIC (μg/ml) for strain carrying gene, with indicated IPTG concn (mM)a
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
evgA
|
baeR
|
cpxRb
|
dcuR
|
||||||||
0.01 | 0.1 | 1 | 0.01, 0.1 | 1 | 0.01 | 0.1, 1 | 0.01 | 0.1 | 1 | ||
Erythromycin | 3.13 | 12.5 | 25 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 6.25 | 6.25 |
Kanamycin | 3.13 | 3.13 | 3.13 | 1.56 | 3.13 | 3.13 | 3.13 | 12.5 | 3.13 | 3.13 | 3.13 |
Fosfomycin | 1.56/0.78d | 1.56 | 0.78 | 0.78 | 1.56/0.78d | 0.78 | 1.56 | 0.78 | 1.56 | 0.78 | 0.78 |
Doxorubicin | 3.13 | 100 | 25 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 |
Novobiocin | 0.78 | 3.13 | 0.78 | 0.78 | 6.25 | 6.25 | 0.78 | 3.13 | 0.78 | 3.13 | 3.13 |
Crystal violet | 0.78 | 3.13 | 1.56 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 1.56 |
Ethidium bromide | 25 | 50 | 50 | 25 | 25 | 25 | 12.5 | 12.5 | 25 | 25 | 25 |
Rhodamine 6G | 6.25 | 100 | 25 | 3.13 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 |
Methyl viologen | 100 | 100 | 50 | 50 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
TPP | 6.25 | 25 | 25 | 6.25 | 6.25 | 6.25 | 3.13 | 6.25 | 6.25 | 6.25 | 6.25 |
Benzalkonium | 3.13 | 25 | 12.5 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 |
SDS | 50 | 400 | 50 | 50 | 100 | 100 | 50 | 50 | 50 | 100 | 100 |
Deoxycholate | 1,250 | >40,000 | 1,250 | 1,250 | >40,000 | 1,250 | 1,250 | >40,000 | 1,250 | 20,000 | 20,000 |
Values in boldface are larger than values for the control strain KAM3 harboring pTrc99A. IPTG at 0.01, 0.1, or 1 mM was added to the agar plates. pTrcarcA, pTrcatoC, pTrcb2381, pTrcbasR, pTrccheB, pTrccheY, pTrccreB, pTrcglnG, pTrchydG, pTrcphoB, pTrcphoP, pTrcrssB, pTrcuhpA, pTrcuvrY, pTrcyfhA, pTrcygiX, and pTrcylcA did not affect the MICs. The MICs of chloramphenicol, tetracycline, minocycline, nalidixic acid, norfloxacin, enoxacin, rifampin, polymyxin B, acriflavine, and carbonyl cyanide m-chlorophenylhydrazone did not change.
pTrccpxR conferred amikacin resistance (MIC of 1.56 μg/ml for KAM3 versus 6.25 μg/ml for KAM3/pTrccpxR).
The growth of the KAM3 strain carrying pTrcfimZ was inhibited with 1,250 μg of deoxycholate per ml; however, the growth recovered with 10,000 to 40,000 μg/ml.
The fosfomycin MIC for host and baeR cells was 1.56 μg/ml with 0.01 and 1 mM IPTG and 0.78 μg/ml with 0.1 mM IPTG.